Activists demand more cost cuts

These two medical industry leaders are facing demands from activists to expand their current cost-cutting plans. While that pressure helps draw investor attention to their high-quality assets, Pfizer is your better choice for long-term gains.
PFIZER INC. $30 is a buy. The company (New York symbol PFE; Manufacturing… Read More